Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,200 | -19,600 | -44,200 | -39,500 | N/A |
| Depreciation Amortization | 64,600 | 51,300 | 37,100 | 18,400 | N/A |
| Income taxes - deferred | -32,100 | -27,800 | -11,500 | -11,800 | N/A |
| Accounts receivable | -8,800 | -11,800 | -12,300 | -4,700 | N/A |
| Accounts payable and accrued liabilities | 9,200 | -4,800 | 8,100 | 300 | N/A |
| Other Working Capital | 120,800 | 139,000 | 85,900 | 91,400 | N/A |
| Other Operating Activity | -107,900 | -98,200 | 4,300 | 17,700 | 0 |
| Operating Cash Flow | $18,600 | $28,100 | $67,400 | $71,800 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -18,000 | -14,600 | -11,600 | -7,100 | N/A |
| Net Acquisitions | 379,100 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -147,800 | -101,000 | -36,600 | 0 | N/A |
| Sale Of Investment | 61,100 | 36,800 | 25,000 | 15,300 | N/A |
| Other Investing Activity | 0 | 379,100 | 32,500 | 0 | 0 |
| Investing Cash Flow | $274,400 | $300,300 | $9,300 | $8,200 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -226,400 | -226,400 | -120,000 | -70,000 | N/A |
| Common Stock Issued | 91,800 | 90,000 | 50,100 | 26,500 | N/A |
| Other Financing Activity | -16,000 | -13,100 | -5,100 | -5,000 | 0 |
| Financing Cash Flow | $-150,600 | $-149,500 | $-75,000 | $-48,500 | $N/A |
| Exchange Rate Effect | -600 | -700 | -300 | 400 | N/A |
| Beginning Cash Position | 117,000 | 117,000 | 117,000 | 117,000 | N/A |
| End Cash Position | 258,800 | 295,200 | 118,400 | 148,900 | N/A |
| Net Cash Flow | $141,800 | $178,200 | $1,400 | $31,900 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,600 | 28,100 | 67,400 | 71,800 | N/A |
| Capital Expenditure | -18,000 | -14,600 | -11,600 | -7,100 | N/A |
| Free Cash Flow | 600 | 13,500 | 55,800 | 64,700 | 0 |